Stay updated with breaking news from Stephen Hytha. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Shares of Pacific Biosciences of California traded to a new 52-week high after the firm reported that a Softbank Group subsidiary will invest $900 million to support its growth initiatives.
Natural Resources Firm Obtains Mining Department Approval for West Iberian Belt Project Drilling News Update Streetwise Reports (2/5/21) Emerita Resources reported it received approval for Infanta Deposit drilling from the Huelva Mining Department for its West Iberian Belt Cu-Pb-Zn-Ag project in Spain. La Infanta Drilling Locations In a news release, Emerita Resources Corp. (EMO:TSX.V; EMOTF:OTCMKTS; LLJA:FSE) announced that it has been granted approval for its planned drill program's restoration plan at the Infanta Deposit on the Iberia Belt West (IBW) project from the Department ...
Source: Streetwise Reports (2/3/21) Shares of GW Pharmaceuticals reached a new 52-week high after the company reported it agreed to be acquired by Jazz Pharmaceuticals in a combination cash and stock deal for $220.00 per share. Biopharmaceutical firm GW Pharmaceuticals Plc (GWPH:NASDAQ), which utilizes its proprietary cannabinoid product platform to develop and commercialize new medicines across a broad range of disease areas, and global biopharmaceutical company Jazz Pharmaceuticals Plc (JAZZ:NASDAQ), announced that the companies have entered into a definitive agreeme...
Gold Explorer's Plan of Operations Certified Complete by Bureau of Land Management News Update Gold Standard Ventures reports that this designation is an important milestone in the permitting process. RC drill at the Pinion North Zone In a news release, Gold Standard Ventures Corp. (GSV:TSX.V; GSV:NYSE) announced that the Bureau of Land Management Nevada (BLM) issued a ruling that the company's Plan of Operations for its South Railroad Project (SRP) is deemed to be complete. The firm noted that the recently submitted Plan of Operations provides a detailed outline of its plans for cons...
Source: Streetwise Reports (2/1/21) Shares of Viela Bio traded higher after it was announced that the company entered into a definitive agreement to be acquired by Horizon Therapeutics for $53.00 per share. Prior to the opening of U.S. market for trading today, clinical-stage biotechnology firm Viela Bio Inc. (VIE:NASDAQ), which is focused on pioneering treatments for autoimmune and severe inflammatory diseases and Horizon Therapeutics Plc (HZNP:NASDAQ), announced that the companies have "entered into a definitive agreement under which Horizon will acquire all of the i...